Austin G. Duffy
0000-0001-9277-0157
Publication & Citation Trends
Most Cited Works
Publications
171 total
487 Allelic Distribution of KRAS Oncogenic Mutations across 1,147 Solid Tumors
Cited by 0
Semantic Scholar
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab
Cited by 13
Semantic Scholar
Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy OA
Cited by 0
Semantic Scholar
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial PDF
Cited by 383
OpenAlex
Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma OA
Cited by 3
Semantic Scholar
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer OA
Cited by 50
Semantic Scholar
Multispecialty surgical management of large clavicular tumor: A case report OA
Cited by 0
Semantic Scholar
Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome OA
Cited by 0
Semantic Scholar
Targeting KRAS in Pancreatic Cancer OA
Cited by 31
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(47)
Hepatocellular Carcinoma Treatment and Prognosis
(40)
Colorectal Cancer Treatments and Studies
(32)
Pancreatic and Hepatic Oncology Research
(30)
Cancer Genomics and Diagnostics
(23)
Frequent Co-Authors
Affiliations
University College Dublin
National Institutes of Health
Memorial Sloan Kettering Cancer Center
University of Michigan–Ann Arbor
Medical Protective